Cargando…
Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome
Barth syndrome (BTHS) is a cardiomyopathy caused by the loss of tafazzin, a mitochondrial acyltransferase involved in the maturation of the glycerophospholipid cardiolipin. It has remained enigmatic as to why a systemic loss of cardiolipin leads to cardiomyopathy. Using a genetic ablation of tafazzi...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734842/ https://www.ncbi.nlm.nih.gov/pubmed/26697888 http://dx.doi.org/10.15252/emmm.201505644 |
_version_ | 1782412983527276544 |
---|---|
author | Dudek, Jan Cheng, I‐Fen Chowdhury, Arpita Wozny, Katharina Balleininger, Martina Reinhold, Robert Grunau, Silke Callegari, Sylvie Toischer, Karl Wanders, Ronald JA Hasenfuß, Gerd Brügger, Britta Guan, Kaomei Rehling, Peter |
author_facet | Dudek, Jan Cheng, I‐Fen Chowdhury, Arpita Wozny, Katharina Balleininger, Martina Reinhold, Robert Grunau, Silke Callegari, Sylvie Toischer, Karl Wanders, Ronald JA Hasenfuß, Gerd Brügger, Britta Guan, Kaomei Rehling, Peter |
author_sort | Dudek, Jan |
collection | PubMed |
description | Barth syndrome (BTHS) is a cardiomyopathy caused by the loss of tafazzin, a mitochondrial acyltransferase involved in the maturation of the glycerophospholipid cardiolipin. It has remained enigmatic as to why a systemic loss of cardiolipin leads to cardiomyopathy. Using a genetic ablation of tafazzin function in the BTHS mouse model, we identified severe structural changes in respiratory chain supercomplexes at a pre‐onset stage of the disease. This reorganization of supercomplexes was specific to cardiac tissue and could be recapitulated in cardiomyocytes derived from BTHS patients. Moreover, our analyses demonstrate a cardiac‐specific loss of succinate dehydrogenase (SDH), an enzyme linking the respiratory chain with the tricarboxylic acid cycle. As a similar defect of SDH is apparent in patient cell‐derived cardiomyocytes, we conclude that these defects represent a molecular basis for the cardiac pathology in Barth syndrome. |
format | Online Article Text |
id | pubmed-4734842 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-47348422016-02-09 Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome Dudek, Jan Cheng, I‐Fen Chowdhury, Arpita Wozny, Katharina Balleininger, Martina Reinhold, Robert Grunau, Silke Callegari, Sylvie Toischer, Karl Wanders, Ronald JA Hasenfuß, Gerd Brügger, Britta Guan, Kaomei Rehling, Peter EMBO Mol Med Research Articles Barth syndrome (BTHS) is a cardiomyopathy caused by the loss of tafazzin, a mitochondrial acyltransferase involved in the maturation of the glycerophospholipid cardiolipin. It has remained enigmatic as to why a systemic loss of cardiolipin leads to cardiomyopathy. Using a genetic ablation of tafazzin function in the BTHS mouse model, we identified severe structural changes in respiratory chain supercomplexes at a pre‐onset stage of the disease. This reorganization of supercomplexes was specific to cardiac tissue and could be recapitulated in cardiomyocytes derived from BTHS patients. Moreover, our analyses demonstrate a cardiac‐specific loss of succinate dehydrogenase (SDH), an enzyme linking the respiratory chain with the tricarboxylic acid cycle. As a similar defect of SDH is apparent in patient cell‐derived cardiomyocytes, we conclude that these defects represent a molecular basis for the cardiac pathology in Barth syndrome. John Wiley and Sons Inc. 2015-12-23 2016-02 /pmc/articles/PMC4734842/ /pubmed/26697888 http://dx.doi.org/10.15252/emmm.201505644 Text en © 2015 The Authors. Published under the terms of the CC BY 4.0 license This is an open access article under the terms of the Creative Commons Attribution 4.0 (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Dudek, Jan Cheng, I‐Fen Chowdhury, Arpita Wozny, Katharina Balleininger, Martina Reinhold, Robert Grunau, Silke Callegari, Sylvie Toischer, Karl Wanders, Ronald JA Hasenfuß, Gerd Brügger, Britta Guan, Kaomei Rehling, Peter Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome |
title | Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome |
title_full | Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome |
title_fullStr | Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome |
title_full_unstemmed | Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome |
title_short | Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome |
title_sort | cardiac‐specific succinate dehydrogenase deficiency in barth syndrome |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734842/ https://www.ncbi.nlm.nih.gov/pubmed/26697888 http://dx.doi.org/10.15252/emmm.201505644 |
work_keys_str_mv | AT dudekjan cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome AT chengifen cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome AT chowdhuryarpita cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome AT woznykatharina cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome AT balleiningermartina cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome AT reinholdrobert cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome AT grunausilke cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome AT callegarisylvie cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome AT toischerkarl cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome AT wandersronaldja cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome AT hasenfußgerd cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome AT bruggerbritta cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome AT guankaomei cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome AT rehlingpeter cardiacspecificsuccinatedehydrogenasedeficiencyinbarthsyndrome |